Check patentability & draft patents in minutes with Patsnap Eureka AI!

Chiral synthetic method of temsirolimus

A technology for temsirolimus and chiral synthesis, applied in the field of organic compound synthesis, can solve the problems of low yield, many reaction steps and high production cost, and achieve the effects of high yield, simple steps and low cost

Inactive Publication Date: 2014-03-26
RAFFLES PHAMRMATECH CO LTD
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In 1994, Jerauld, S.Skotnicki, etc. reported the preparation methods and biological activities of temsirolimus for the first time (US5362718). Propionic acid reacts with 2,4,6-trichlorobenzoyl chloride to obtain acid anhydride, and then condenses with rapamycin to obtain intermediate A-1 through isolation, and finally deprotects to obtain temsirolimus, but The disadvantage of this method is that the separation of the by-product and the product of the simultaneous esterification of the 31 and 42 hydroxyl groups is difficult, and the total yield is 20%.
Although this method can increase the total yield to 47%, the disadvantage is that there are many reaction steps and the operation process is cumbersome
Based on the synthetic route of Shaw, Chia-Cheng, etc., Warren, Chew, etc. used phenylboronic acid to protect 2,2-dimethylolpropionic acid, and finally deprotected it with 2-methyl-2,4-pentanediol to obtain Tesirolimus (US2005033046), although the yield of the method is high, the production cost is also high
In summary, the preparation method of temsirolimus provided by existing literature has the disadvantages of low yield, many reaction steps, cumbersome operation process and high production cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chiral synthetic method of temsirolimus
  • Chiral synthetic method of temsirolimus
  • Chiral synthetic method of temsirolimus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The synthetic method of the temsirolimus precursor according to the present embodiment comprises the following steps:

[0034] (1) Preparation of 2,2,5-trimethyl-1,3-dioxane-5-carboxylic acid-1-methylbenzylthiophenol ester (chiral benzylthiophenol ester): 1g 2,2, 5-Trimethyl-1,3-dioxane-5-carboxylic acid, 1.4g (1.5eq) N,N-dicarbonylimidazole (CDI), N 2 For protection, add 10ml of dichloromethane at room temperature, cool down to 0°C, stir for 1h, slowly drop in 0.87g (1.1eq) (S)-1-methylbenzylthiophenol, react at 0°C for 2h, and monitor the reaction by TLC. After the reaction was completed, it was diluted with dichloromethane, washed with water, washed with saturated brine, dried and concentrated. The residue was subjected to silica gel column chromatography, and n-hexane:ethyl acetate (20:1) was quickly eluted to obtain about 1.5 g of chiral benzylthiophenol ester with a yield of 90%.

[0035] (2) Add 0.5g rapamycin, 0.12g TBD, 10mL dichloromethane to the flask, unde...

Embodiment 2

[0037] The synthetic method of the temsirolimus precursor according to the present embodiment comprises the following steps:

[0038] (1) Preparation of 2,2,5-trimethyl-1,3-dioxane-5-carboxylic acid-2-butanol ester (chiral butanol ester): 1g 2,2,5-trimethyl Dioxin-1,3-dioxane-5-carboxylic acid, 35mg (0.05eq) DMAP, 1.77g (1.5eq) DCC, N 2 For protection, dichloromethane was added at room temperature, the temperature was lowered to 0°C, stirred for 1 h, 0.47 g (S)-2-butanol was slowly added dropwise, reacted at 0°C for 3 h, and the reaction was monitored by TLC. After the reaction was completed, it was diluted with dichloromethane, washed with water, washed with saturated brine, dried over anhydrous magnesium sulfate, and distilled under reduced pressure. Butanol ester 1.2g, 92% yield.

[0039] (2) 0.5g rapamycin, 0.12g TBD, 10mL dichloromethane, nitrogen protection, stirring, dropwise add 0.188g (1.5eq) chiral butanol ester, react at room temperature 25°C for 5h, TLC until the...

Embodiment 3

[0041] The synthetic method of the temsirolimus precursor according to the present embodiment comprises the following steps:

[0042] (1) Preparation of 2,2,5-trimethyl-1,3-dioxane-5-carboxylic acid phenylethyl alcohol ester (chiral phenylethyl alcohol ester): 1g 2,2,5-trimethyl-1 ,3-Dioxane-5-carboxylic acid, 1.4g (1.5eq) N, N-dicarbonylimidazole (CDI), N 2For protection, add 10mL of dichloromethane at room temperature, cool down to 0°C, stir for 1h, slowly add 0.77g (1.1eq) (S)-(-)-1-phenylethanol dropwise, react at 0°C for 2h, and monitor the reaction by TLC. After the reaction was completed, it was diluted with dichloromethane, washed with water, washed with saturated brine, dried and concentrated. The residue was subjected to silica gel column chromatography with n-hexane:ethyl acetate (20:1) for rapid elution to obtain about 1.37 g of chiral phenylethyl alcohol ester with a yield of 86%.

[0043] (2) Add 0.5g rapamycin, 0.12g TBD, 10mL dichloromethane to the flask, und...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of organic compound synthesis, and particularly relates to a chiral synthetic method of temsirolimus. A chiral synthetic method of temsirolimus comprises the following steps: reacting rapamycin with a chiral compound to generate a synthetic temsirolimus precursor, and then hydrolyzing the temsirolimus precursor into temsirolimus. In the invention, a chiral ester compound is used for direct reaction with rapamycin, the space effect of the chiral compound is used, so that the reaction is carried out in a single point of reaction, and the whole reaction has selectivity. Therefore, the invention provides a temsirolimus synthetic method with simple procedure, high yield and low cost and suitable for industrial production.

Description

technical field [0001] The invention relates to the field of organic compound synthesis, in particular to a chiral synthesis method of temsirolimus. Background technique [0002] Tesirolimus (temsirolimus), also known as temsirolimus ester compound; rapamycin 42-[-3-hydroxyl 2-(hydroxymethyl)-2-methacrylate, which is a kind of The medicine (now merged into Pfizer) develops a targeted antineoplastic drug for the treatment of advanced renal cancer, and is also the first targeted therapy drug for the treatment of renal cancer, and is the only marketed drug that specifically inhibits mTOR kinase . The mTOR kinase is an important protein for regulating cell proliferation, growth and cell survival. In vitro studies have found that the inhibition of mTOR kinase by temsirolimus leads to a decrease in the level of certain angiogenic growth factors such as vascular endothelial growth factor, thereby preventing the development of new blood vessels, resulting in the death of cancer ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D498/18
CPCC07D498/18
Inventor 叶伟平徐俊烨肖诗华黄志宁吴鸿翔陈飞谢香兰
Owner RAFFLES PHAMRMATECH CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More